International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases

Plain-language summary

This is an international registry study following patients with neutral lipid storage disease (NLSD) / triglyceride deposit cardiomyovasculopathy (TGCV) and related conditions. It includes patients diagnosed with NLSD / TGCV. It is a non-phase study and is currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Recruiting

Sponsor

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

Start date

1/1/2014

Estimated completion

3/31/2028

Countries

United States, Austria, China, France, Germany, Italy, Japan, Netherlands, United Kingdom

Related genes

Locations

• Stanford, United States
• New York, United States
• Graz, Austria
• Beijing, China
• Paris, France
• Munich, Germany
• Rome, Italy
• Rome, Italy
• Milan, Italy
• Padova, Italy
• Suita, Japan
• Kodaira, Japan
• Maastricht, Netherlands
• Harefield, United Kingdom
• Newcastle upon Tyne, United Kingdom

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Patients who are diagnosed with NLSD / TGCV

Exclusion Criteria:

* None